- Home
- ORGO vs EVGO Comparison
ORGO vs EVGO Comparison
Compare ORGO & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- EVGO
- Stock Information
- Founded
- ORGO 1985
- EVGO 2010
- Country
- ORGO United States
- EVGO United States
- Employees
- ORGO N/A
- EVGO N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- EVGO Other Specialty Stores
- Sector
- ORGO Health Care
- EVGO Consumer Discretionary
- Exchange
- ORGO Nasdaq
- EVGO Nasdaq
- Market Cap
- ORGO 465.6M
- EVGO 532.0M
- IPO Year
- ORGO N/A
- EVGO N/A
- Fundamental
- Price
- ORGO $4.89
- EVGO $4.04
- Analyst Decision
- ORGO Buy
- EVGO Strong Buy
- Analyst Count
- ORGO 2
- EVGO 10
- Target Price
- ORGO $7.50
- EVGO $6.10
- AVG Volume (30 Days)
- ORGO 642.5K
- EVGO 4.9M
- Earning Date
- ORGO 08-07-2025
- EVGO 08-05-2025
- Dividend Yield
- ORGO N/A
- EVGO N/A
- EPS Growth
- ORGO N/A
- EVGO N/A
- EPS
- ORGO N/A
- EVGO N/A
- Revenue
- ORGO $429,531,000.00
- EVGO $308,365,000.00
- Revenue This Year
- ORGO $2.57
- EVGO $45.45
- Revenue Next Year
- ORGO $9.80
- EVGO $26.93
- P/E Ratio
- ORGO N/A
- EVGO N/A
- Revenue Growth
- ORGO N/A
- EVGO 49.06
- 52 Week Low
- ORGO $2.46
- EVGO $2.20
- 52 Week High
- ORGO $6.71
- EVGO $9.07
- Technical
- Relative Strength Index (RSI)
- ORGO 59.08
- EVGO 58.21
- Support Level
- ORGO $4.41
- EVGO $3.80
- Resistance Level
- ORGO $4.90
- EVGO $4.34
- Average True Range (ATR)
- ORGO 0.30
- EVGO 0.29
- MACD
- ORGO -0.03
- EVGO 0.04
- Stochastic Oscillator
- ORGO 92.58
- EVGO 70.91
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About EVGO EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.